Aytu Biopharma agrees to merge with Rosemont Pharmaceuticals
Aytu Biopharma entered into an Agreement and Plan of Merger with Rosemont Pharmaceuticals Holdings to let Rosemont acquire the company on November 16, 2026. The deal highlights a significant corporate restructuring.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed